Use of a High-Purity Factor X (FX) Concentrate In Six Turkish Patients with Hereditary FX Deficiency

Basit Öğe Kaydı
dc.contributor.authorKavakli, K.
dc.contributor.authorOner, A. F.
dc.contributor.authorCelkan, T.
dc.contributor.authorTimur, C.
dc.contributor.authorNorton, M.
dc.date.accessioned2019-10-27T23:11:27Z
dc.date.available2019-10-27T23:11:27Z
dc.date.issued2016
dc.departmentEge Üniversitesien_US
dc.identifier.endpage95en_US
dc.identifier.issn1351-8216
dc.identifier.issn1365-2516
dc.identifier.startpage94en_US
dc.identifier.urihttps://hdl.handle.net/11454/53078
dc.identifier.volume22en_US
dc.identifier.wosWOS:000374485500150en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofHaemophiliaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleUse of a High-Purity Factor X (FX) Concentrate In Six Turkish Patients with Hereditary FX Deficiencyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu